Home 
CONTACT Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.2, p.144–147, 2019
CONTACT Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.2, p.144–147, 2019
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.120, No.2, p.144–147, 2019 |
||
| Title: TNF receptor type 1 and TNF receptor type 2 mRNA expression was not associated with coronary artery disease in a group of Iranian Turks | ||
| Author: M. Bagheri, K. Khadem-Vatani, M. H. Seyed-Mohammad-Zad, I. Abdi Rad, A. Rostamzadeh, B. Rahimi, S. Mahmoudi-Nejad | ||
| Abstract: OBJECTIVES: Present investigation was carried out to evaluate the mRNA level of TNF receptor type 1 (TNFR1) and TNF receptor type 2 (TNFR2) in peripheral-blood cells in patients with premature CAD over healthy controls. BACKGROUND: TNFα as a pleiotropic cytokine could be concerned in cardiovascular pathophysiology regarding its special effects on endothelial cells. TNFα exerts its activities through its receptors, TNFR1 and TNFR2. METHODS: Totally, 40 patients with premature CAD and 40 healthy controls were studied. The qRT-PCR technique was used to determine the mRNA level of TNFR1 and TNFR2 in tested groups. RESULTS: The results of this study show that the relative expression was 1.32 ± 0.34 in cases and 1.11 ± 0.16 in controls for TNFR1. The relative expression was 0.96 ± 0.13 in cases and 1.49 ± 0.41 in controls for TNFR2. There is no significant difference in the level of gene expression in the studied groups regarding TNFR1 and TNFR2 genes (p > 0.05). CONCLUSION: It can be concluded that the mRNA levels of TNFR1 and TNFR2 were not associated with CAD risk. Studies with more details, larger sample size, and new risk loci are necessary to reveal disease-causing mechanisms in the pathogenesis of CAD (Fig. 3, Ref. 21). |
||
| Keywords: gene expression, TNFR1,TNFR2, premature CAD | ||
| Published online: 17-Feb-2019 | ||
| Year: 2019, Volume: 120, Issue: 2 | Page From: 144, Page To: 147 | |
| doi:10.4149/BLL_2019_023 |
||
|
|
 download file |
|